The colony-stimulating factor 1 receptor (CSF-1R), encoded by the c-fms proto-oncogene, exhibits intrinsic, ligand-dependent, protein tyrosine kinase (PTK) activity. Mutations at Leu-301 within the extracellular domain of human CSF-1R unmask its oncogenicity, and induce constitutive receptor PTK activity. In principle, activating mutations in human FMS might contribute to the etiology of myeloid proliferative disorders, including leukemias and myelodysplastic syndromes, but no bona fide activating mutations at codon 301 have thus far been identified.
Specific Aim #1 is to use an unbiased approach to search for additional activating mutations in human FMS gene. Chemically mutagenized FMS """"""""target cassettes"""""""" will be recloned en masse into a parental vector which will be transfected into NIH/3T3 cells. Foci of transformed cells will be isolated, and the relevant portions of their FMS genes will be directly sequenced after amplification of the target cassette by polymerase chain reaction. We expect to catalog alternative activating mutations that may potentially contribute to the neoplastic transformation of cells of the mononuclear phagocyte series. The locations of multiple activating mutations should circumscribe structural motifs within CSF-1R that determine its ligand-independent activation. Signal transduction by CSF-1R involves the association of the autophosphorylated receptor with """"""""downstream"""""""" effectors of the mitogenic response. Selective mutagenesis of mapped sites of receptor autophosphorylation abrogate its ability to couple to these proteins, generating mutants that are partially defective in signal transduction. Mutation of Tyr-809 uncouples the ability of CSF-1R to induce c-myc expression and greatly reduces CSF-1 stimulated mitogenicity. In contrast, the ligand-stimulated CSF-1R[Phe-809] mutant exhibits wild- type levels of PTK activity, binds to a phosphatidylinositol 3-kinase, and induces the activity of c-fos, c-jun and junB with unperturbed kinetics. Introduction of an exogenous c-myc gene into NIH/3T3 cells bearing CSF-1R[Phe-809] restores CSF-1 induced mitogenicity in serum- free medium.
Under Specific Aim #2, we propose to clone the putative cellular effector protein that interacts with CSF-1R in the region flanking PTyr-809, elucidate its function, and study its regulation of CSF-1-responsive genes. The latter experiments focus on mechanisms controlling normal growth which are likely to be perturbed in cancer cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056819-02
Application #
3201237
Study Section
Pathology B Study Section (PTHB)
Project Start
1992-06-12
Project End
1997-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Eischen, C M; Roussel, M F; Korsmeyer, S J et al. (2001) Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol Cell Biol 21:7653-62
Randle, D H; Zindy, F; Sherr, C J et al. (2001) Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages. Proc Natl Acad Sci U S A 98:9654-9
Dervieux, T; Blanco, J G; Krynetski, E Y et al. (2001) Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Cancer Res 61:5810-6
Eischen, C M; Woo, D; Roussel, M F et al. (2001) Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol 21:5063-70
Sasaki, K; Taura, F; Shoyama, Y et al. (2000) Molecular characterization of a novel beta-glucuronidase from Scutellaria baicalensis georgi. J Biol Chem 275:27466-72
Groth, A; Weber, J D; Willumsen, B M et al. (2000) Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J Biol Chem 275:27473-80
Lam, P Y; Sublett, J E; Hollenbach, A D et al. (1999) The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain. Mol Cell Biol 19:594-601
Inoue, K; Roussel, M F; Sherr, C J (1999) Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc Natl Acad Sci U S A 96:3993-8
Sexl, V; Diehl, J A; Sherr, C J et al. (1999) A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene 18:573-82
Eischen, C M; Weber, J D; Roussel, M F et al. (1999) Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13:2658-69

Showing the most recent 10 out of 32 publications